In our study, PD-L1 was expressed on tumor cells in two thymic NEC cases (2/7, 28.6%) and on tumor-infiltrating immune cells in three thymic NEC cases (3/7, 42.9%), which are comparable with the frequency of PD-L1 presence in SCLC (32, 33). The gene discussed is CD274; the disease is neoplasm.